Frankie Fattorini

Biopharma braces for Trump’s tariffs aimed at bringing manufacturing back to the US. Photo by Bloomberg/Bloomberg via Getty Images. As President Trump continues to signal import tariffs on pharmaceuticals to bolster US manufacturing, experts warn this could hike costs and […]

Illustration showing chimeric antigen receptor (CAR) T cells (blue) being used to treat a melanoma (orange). Image source: Getty Images/ NEMES LASZLO/SCIENCE PHOTO LIBRARY As cell and gene therapy developers struggle against an investment slump and competition from established autologous

Biopharma leaders met in Spain to discuss the ways how AI-optimised supply chains can safeguard clinical trials against global trade instability. Credit: gorodenkoff / Getty Images. The role of AI in supply chain management proved to be the focal issue

Machine learning tools can account for innumerable factors outside of regular capabilities, adjusting biopharma material orders for cost, efficiency, emissions, and desired stock. Credit: stocklapse / Getty Images. Widespread integration of machine learning (ML) into supply chain management by major

From the Covid-19 pandemic to Trump’s tariffs, external forces are tempting Europe to seek independent biopharma production, but experts warn the benefits of global trade could render this unfeasible. Credit: ugurhan / Getty Images. In step with international news in

An empowered MSSG will allow the EU to address medicine shortages by enforcing drug sharing between member states. Credit: Frankie Fattorini/ GlobalData Earlier this month, the newly empowered role of the European Union (EU)’s Executive Steering Group on Shortages and

Clinical trial sponsors can expect a “one set of documents paradigm” says Andreas Schwinn, , senior qualified person (QP) for investigational medicinal products (IMPs) at Roche. This should allow faster approvals and counteract drug shortages. Credit: Frankie Fattorini/ GlobalData A

Clinical trial sponsors can expect a “one set of documents paradigm” says Andreas Schwinn, with faster approvals and fewer generic drug shortages. Credit: Frankie Fattorini/ GlobalData A major overhaul and consolidation of EU clinical trial regulations is paving the way

Marcel Walraven, key account director, Biocair, speaking at the Clinical Trial Supply Europe Conference in Barcelona. The difficulties involved in biopharmaceutical transport, rather than stifling international supply, could bolster business for courier middlemen. Credit: Frankie Fattorini/ GlobalData Despite concerns of

Eisbach Bio is developing EIS-12656, which works by inhibiting ALC1 (chromodomain-helicase-DNA-binding protein 1-like), a chromatin remodeller and DNA helicase also involved in DNA repair. Image credit: Shutterstock/PeopleImages.com – Yuri A Eisbach Bio plans to use a $4.75m grant to advance